Peter De Cruz

17PUBLICATIONS
33CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical bacteriologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)Information systems development methodologies and practice
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 18, 2026
Tacrolimus Bridging and Combination Therapy Following Infliximab and JAK Inhibitor Failure in Ulcerative Colitis: A Case Series.

|Mar 02, 2026
Monocyte Distribution Width Differentiates Bacterial Enterocolitis from Acute Severe Ulcerative Colitis in the Emergency Department.

Christopher F D Li Wai Suen, Shipraa Kaul, Ethan X Z Tan

|Jul 15, 2025
Systemic Biologics Have Similar Safety to Vedolizumab in Inflammatory Bowel Disease Patients Following Liver Transplantation.

Simone Chin, Danny Con, Patrick Hilley

|Aug 29, 2024
How Does an Integrated Pharmacist Add Value in the Management of Inflammatory Bowel Disease in the Era of Values-Based Healthcare?

Patrick Hilley, Darren Wong, Peter De Cruz

|Dec 14, 2023
Clinical trial: Combination allopurinol-thiopurine versus standard thiopurine in patients with IBD escalating to immunomodulators (the DECIDER study).

Abhinav Vasudevan, Danny Con, Peter De Cruz

|Sep 19, 2023
Factors Associated With Response to Rescue Therapy in Acute Severe Ulcerative Colitis.

Christopher F D Li Wai Suen, Dean Seah, Matthew C Choy

Pageof 3

Frequent Collaborators

8 joint publications

Matthew Choy

4 joint publications

Christopher F D Li Wai Suen

3 joint publications

Danny Con

2 joint publications

Simone Chin